Stifel Financial Corp Biogen Inc. Transaction History

Stifel Financial Corp

$85.8 Billion
Q1 2024

A detailed history of Stifel Financial Corp transactions in Biogen Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 59,475 shares of BIIB stock, worth $13.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

59,475

Previous 51,648 15.15%

Holding current value

$13.6 Million

Previous $13.4 Million 4.04%

% of portfolio

0.01%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$212.02 - $267.71 $1.66 Million - $2.1 Million	7,827 Added 15.15%	59,475 $12.8 Million
Q4 2023 Feb 12, 2024	SELL	$222.59 - $267.94 $907,944 - $1.09 Million	-4,079 Reduced 7.32%	51,648 $13.4 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $2.48 Million - $2.8 Million	9,809 Added 21.36%	55,727 $14.3 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $1.71 Million - $1.98 Million	6,213 Added 15.65%	45,918 $13.1 Million
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $469,761 - $535,274	-1,831 Reduced 4.41%	39,705 $11 Million

Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $1.36 Million - $1.66 Million	5,399 Added 14.94%	41,536 $11.5 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $377,503 - $520,543	-1,939 Reduced 5.09%	36,137 $9.65 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $1.3 Million - $1.54 Million	-6,919 Reduced 15.38%	38,076 $7.76 Million
Q1 2022 May 13, 2022	BUY	$193.77 - $244.14 $226,710 - $285,643	1,170 Added 2.67%	44,995 $9.48 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $765,806 - $984,173	-3,420 Reduced 7.24%	43,825 $10.5 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $761,243 - $992,744	-2,690 Reduced 5.39%	47,245 $13.4 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $2.68 Million - $4.29 Million	-10,336 Reduced 17.15%	49,935 $17.3 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $1.73 Million - $2.03 Million	7,125 Added 13.41%	60,271 $16.9 Million
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $169,634 - $255,342	718 Added 1.37%	53,146 $13 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $481,351 - $555,780	-1,818 Reduced 3.35%	52,428 $14.9 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $547,324 - $724,835	-2,116 Reduced 3.75%	54,246 $14.5 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $19.5 Million - $24.7 Million	-72,541 Reduced 56.28%	56,362 $17.9 Million
Q4 2019 Feb 13, 2020	BUY	$220.06 - $304.07 $10.5 Million - $14.5 Million	47,591 Added 58.53%	128,903 $38.2 Million
Q3 2019 Nov 19, 2019	BUY	$217.44 - $243.88 $50,446 - $56,580	232 Added 0.29%	81,312 $18.9 Million
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $15.4 Million - $17.3 Million	-71,007 Reduced 46.69%	81,080 $18.9 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $7.07 Million - $7.8 Million	-32,260 Reduced 17.5%	152,087 $35.6 Million
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $12.7 Million - $19.9 Million	-58,595 Reduced 24.12%	184,347 $43.5 Million
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $747,494 - $946,781	2,684 Added 1.12%	242,942 $73.3 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $5.46 Million - $7.14 Million	18,603 Added 8.39%	240,258 $84.7 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $3.56 Million - $4.24 Million	13,814 Added 6.65%	221,655 $64.2 Million
Q1 2018 May 11, 2018	BUY	$260.13 - $367.91 $4.76 Million - $6.73 Million	18,283 Added 9.65%	207,841 $56.8 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $3.83 Million - $4.29 Million	12,464 Added 7.04%	189,558 $60.5 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $49.8 Million - $58.4 Million	177,094	177,094 $0

Others Institutions Holding BIIB

# of Institutions

1,047

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $33B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Biogen Inc. Transaction History